French healthcare startup Jinko, which supports people affected by cancer through a personalized supportive care service, has raised €2 million in a funding round led by 360 Capital, with support from AFI Ventures, Ventech's impact arm, and 10 angel investors from the medical, entrepreneurial, insurance, and pharmaceutical sectors.
- Founded in 2023 by Faustine Aussedat Bouvier and Anthony Miossec, Jinko offers personalized cancer care through a holistic and multidisciplinary approach, covering areas like dietetics, psychology, physical activity, socio-esthetics, and osteopathy.
- Certified practitioners provide compassionate care, starting with a nurse consultation to assess each patient's needs and create a tailored care plan. The startup also uses its technology to streamline communication and coordination between nurses, patients, and practitioners, ensuring seamless support throughout the care process.
Details of the deal
- The fresh funding was led by 360Capital, a Paris-based venture capital firm that manages €500 million in assets and invests in tech startups across Europe.
"We are delighted to support the talented team at Jinko on the occasion of their first funding round. The topic of supportive care is still too little and poorly addressed today, and we are convinced that the approach developed by the company will benefit the greatest number," Partners at 360 Capital, Clara Cornu, and Alexandre Mordacq, commented.
- AFI Ventures, Ventech's impact arm and a venture capital firm that supports seed and pre-seed startups with investments ranging from €500,000, along with 10 business angels from the medical, entrepreneurial, insurance, and pharmaceutical sectors, also participated in the funding round.
- The new funding will help Jinko expand partnerships within the healthcare sector, increase its visibility among medical professionals, and enhance its digital platform to provide even more personalized and accessible care.
